Publication | Open Access

Phase 1 study of anti-CD47 monoclonal antibody CC-90002 in patients with relapsed/refractory acute myeloid leukemia and high-risk myelodysplastic syndromes

Hematological MalignancyMedicineHematologyImmunologyHigh-risk Myelodysplastic SyndromesMyeloid NeoplasiaImmunotherapyOncologyRadiation OncologyPhase 1Health Sciences